FIELD: organic chemistry, virology, pharmacy. SUBSTANCE: invention describes the novel derivatives of benzothiophene, benzofuran, indolethiazepinone, oxazepinone and diazepinone of the formula (I) 
where: R1-R6, X and Y have values given in p. 1 of the invention claim, and their pharmaceutically acceptable acid-additive salts. The proposed heterocyclic compounds can be used as an active component of a pharmaceutical composition showing capacity to inhibit cellular adhesion or HIV-activity. Except for, these compounds can be used for inhibition of leukocytes adhesion to endothelial cells in treatment of sicknesses caused with its, for example, inflammatory sickness and also for treatment of humans and animals infected with HIV-infection. EFFECT: new compounds indicated above, enhanced effectiveness of treatment. 15 cl, 2 tbl, 12 ex
| Title |
Year |
Author |
Number |
| DERIVATIVES OF 3-ALKYLHYDROXY-, ARYLHYDROXY- OR ARYLALKYLHYDROXY[B]THIOPHENE-2-CARBOXAMIDE, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY INHIBITING ADHESION OF LEUKOCYTES TO VASCULAR ENDOTHELIUM |
1993 |
- Dajen Khehrris Boskelli
- Dehvid Tomas Konnor
- Klifford Din Rajt
|
RU2117665C1 |
| METHOD FOR INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR THYROSINEKINASE, NITROGEN-CONTAINING TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR INTRODUCING EPIDERMAL GROWTH FACTOR RECEPTOR THYROSINEKINASE INHIBITOR LIKE ERB- B2, ERB-B3 OR ERB-B4 AND CONTRACEPTIVE COMPOSITION |
1995 |
- Aleksander Dzhejms Bridzhes
- Uilliam Aleksander Dehnni
- Dehvid Fraj
- Alan Krejker
- Robert Majer
- Gordon Uilliam Rukasl
- Andru Mark Tompson
- Khauard Dehniel Khollis Shoualter
|
RU2158127C2 |
| DERIVATIVES OF BENZOTHIAZINE DIOXIDE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF SHOWING INHIBITORY ACTIVITY OF ENDOTHELIN RECEPTOR AND METHOD OF INHIBITION OF ENDOTHELIN RECEPTOR |
1996 |
- Kent Ehlen Berrimehn
- Ehmi Mehj Bunker
- Annete Mehriehn Doehrti
- Dzheremi Dzhon Ehdmunds
|
RU2164225C2 |
| METHODS OF INHIBITION OF TYROSINE KINASE ACTIVITY IN EPIDERMAL GROWTH FACTOR RECEPTORS, BICYCLIC PYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY INHIBITING ACTIVITY OF TYROSINE KINASE IN EPIDERMAL GROWTH FACTOR RECEPTORS AND COMPOSITION ELICITING CONTRACEPTIVE EFFECT |
1995 |
- Aleksander Dzhejms Bridzhes
- Uilliam Aleksander Dehnni
- Dehvid Fraj
- Alan Krejker
- Robert Majer
- Gordon Uilliam R'Jukastl
- Ehndrju Mark Tompson
|
RU2174980C2 |
| METHOD OF SYNTHESIS OF (S)-(-)- AND (R)-(+)-ISOMERS OF (5-AMINO-1,2-DIHYDRO-2-METHYL-3-PHENYLPYRIDO-[3,4-B]-PYRAZINE- -7-YL)-CARBAMIDE ACID ETHYL ESTER OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND INTERMEDIATE (S)-(-)- AND (R)-(+)-ISOMERS OF [6-AMINO-4-[[2-(ALKOXYALKYLAMINO)-1-METHYL-2-OXOETHYL]-AMI- -NO]-5-NITRO-2-PYRIDINYL]-CARBAMIDE ACID ETHYL ESTER |
1994 |
- Om Prakash Goehl[Us]
- Sham Shridkhar Nikam[In]
|
RU2098409C1 |
| SULFAMIC ACID ESTERS, PHARMACEUTICAL COMPOSITION FOR CONTROL OF CHOLESTEROL CONCENTRATION, METHOD OF TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA, METHOD OF TREATMENT OF PATIENTS WITH ATHEROSCLEROSIS |
1994 |
- Khelen Tsenvej Li
- Dzhozef Armend Pikard
- Drago Robert Sliskovits
- Vendell Virendzhe
|
RU2137756C1 |
| METHOD OF PRODUCING NAPHTHYLIDIENE AND QUINOLINE COMPOUNDS |
0 |
|
SU1192624A3 |
| METHOD OF PRODUCING NAPHTHYRYDINE QUINOLINE- OR BENZOXAZINE CARBOLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS OF ACID ADDITION |
0 |
- Taunli P.Kulbertson
- Dzhon M.Domagala
- Tomas F.Mich
- Dzheffri B.Nikols
|
SU1360584A3 |
| DERIVATIVES OF INDOLE, THEIR TAUTOMERS, MIXTURES OF THEIR ISOMERS OR SEPARATE ISOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTITUMOR OR INHIBITING PROTEIN TYROSINE KINASE ACTIVITY AND METHOD OF INHIBITION OF PROTEIN TYROSINE KINASE-DEPENDING DISEASE OR CONTROL OF ABERRANT GROWTH OF MAMMALIAN OR HUMAN CELLS |
1993 |
- Dobrasin Ehllen Mira
- Shovol'Ter Khovord Dehniel' Khollis
- Denni Uilliehm Aleksander
- Pal'Mer Brajn Desmond
- Rjukasel' Gordon Uilliehm
- Tersel' Moehna
- Tomson Ehndrju Mark
|
RU2155187C2 |
| ARYLTHIOCOMPOUNDS, METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITION |
1995 |
- Dzhon Majkl Domadzhela
- Ehdvard Fejtz Ehlslejdzher
- Rokko Din Dzholiotti
|
RU2156236C2 |
